Save with our NEW Annual Plan pricing! Register today

Education:
  • Biomedical Sciences (Kings College London)
  • Neuropharmacology PhD (Oxford University)
  • Nutritional Medicine BSc, AFMCP (Institute of Functional Medicine Qualification)
Awards:
  • Paton Scholar, Oxford University
Previous Experience:

Dr. Philipps has focused on the ECS, writing and speaking in various journals and media. She regularly speaks at health conferences and founded The Bliss Programme to optimise ECS health.

Doctor Elisabeth Philipps

Dr Philipps is a clinical neuroscientist specialising in the endocannabinoid system (ECS), medical cannabis, CBD, and integrative medicine. She is passionate about empowering individuals to manage their health through lifestyle, diet, and plant-based medicines. As Clinical Lead at the Medical Cannabis Alliance, she advances cannabinoid medicine research, access, and policy reforms in the UK.

Dr Philipps expanded her research and clinical skills into integrative medicine due to her own experience with chronic fatigue syndrome (CFS); she used her health as a subject and made a full recovery, enabling her to further help others with chronic conditions.

Doctor Elisabeth Philipps has also written in:

Top Articles by Doctor Elisabeth Philipps

Watch Dr Elisabeth Philipps in conversation with Dr Mikael Sodergren and find out about the latest cannabinoid research

25th January 2022

Webinar: Chronic Pain and Medical Cannabis

11th November 2021

Free medical cannabis education series for patients, carers and clinicians

1st September 2021

Our Other Authors

Dr Sodergren is a specialist in complex pancreas, liver, and gallbladder surgeries, including keyhole and robotic techniques. He leads clinical and pre-clinical cannabinoid research at Curaleaf International and has published over 150 peer-reviewed articles. Dr Sodergren holds an internationally patented surgical device.
Dr Erridge specialises in medical cannabis research, with a focus on chronic pain. As Research Director at Curaleaf Clinic, he oversees the UK Medical Cannabis Registry. Dr Erridge has published over 80 peer-reviewed articles and is completing a PhD at Imperial College London. His expertise includes medical technologies and patient-reported outcome measures.
Dr Rucker specialises in mood disorders and novel psychopharmacological treatments for treatment-resistant depression. He leads the Psychoactive Trials Group at the Centre for Affective Disorders and holds a Clinician Scientist Fellowship to investigate psilocybin. Dr Rucker has over 15 years of psychiatric experience and extensive clinical trial expertise.